Iguana Healthcare Management’s Teva Pharmaceuticals TEVA Stock Holding History

Iguana Healthcare Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-150,000	Closed	-$9.85M	–	85
2015 Q4	$9.85M	Buy	150,000 +50,000	+50%	+$3.09M	3.24%	8
2015 Q3	$5.65M	Buy	100,000 +25,000	+33%	+$1.62M	2.22%	13
2015 Q2	$4.43M	Buy	+75,000	New	+$4.63M	1.4%	28
2014 Q3	–	Sell	-50,000	Closed	-$2.62M	–	80
2014 Q2	$2.62M	Hold	50,000	–	–	1.22%	34
2014 Q1	$2.64M	Buy	+50,000	New	+$2.31M	1.22%	33

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Iguana Healthcare Management's TEVA Position: Q1 2016 in Review

Iguana Healthcare Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2016, closing a stake of 150,000 shares — an estimated $9.85M sold.

Iguana Healthcare Management first reported a position in TEVA in Q1 2014 and held it in 5 quarters. The position peaked at $9.85M in Q4 2015. 837 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

Iguana Healthcare Management reported no remaining Teva Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Iguana Healthcare Management sold 150,000 Teva Pharmaceuticals shares in Q1 2016, an estimated $9.85M.
Iguana Healthcare Management first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 5 quarters.
Iguana Healthcare Management's Teva Pharmaceuticals position peaked at $9.85M in Q4 2015.
837 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2016.

Based on Iguana Healthcare Management's 13F filing for Q1 2016, filed 17 May 2016.